{
  "id": "6206c22ac9dfcb9c0900003e",
  "type": "factoid",
  "question": "Which signaling pathway does LY294002 inhibit?",
  "ideal_answer": "LY294002, can block the PI3K/AKT signaling pathway.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/34820336"
  ],
  "snippets": [
    {
      "text": "LY294002 Is a Promising Inhibitor to Overcome Sorafenib Resistance in FLT3-ITD Mutant AML Cells by Interfering With PI3K/Akt Signaling Pathway.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34820336",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "PI3K inhibitor, LY294002, can block PI3K/AKT signaling, further inhibit glycolysis to disturb ATP production, and finally induce cell apoptosis. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34820336",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "PI3K/AKT"
}